10x Genomics Inc (TXG)
26.42
-0.83
(-3.05%)
USD |
NASDAQ |
May 07, 10:08
10x Genomics Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
Date | Value |
---|---|
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 29.72M |
September 30, 2019 | 29.69M |
June 30, 2019 | 29.66M |
March 31, 2019 | 0.00 |
December 31, 2018 | 29.68M |
September 30, 2018 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
29.72M
Maximum
Dec 2019
4.454M
Average
--
Median
Mar 2020
Total Long Term Debt (Quarterly) Benchmarks
Teladoc Health Inc | 1.540B |
American Shared Hospital Services | 17.59M |
Novo Integrated Sciences Inc | 3.279M |
Astrana Health Inc | 278.44M |
Cryo-Cell International Inc | 10.53M |